Exactech (NSDQ:EXAC) said today that it acquired knee replacement surgery instrument maker XpandOrtho for an undisclosed amount. Gainesville, Fla.-based Exactech said that it plans to incorporate XpandOrtho’s soft tissue balancing technology into its ExactechGPS computer-assisted surgery system designed to support shoulder and knee replacements. “This allows our technology, which has been in development for more than […]
Business/Financial News
Wall Street Beat | Earnings Reports | Funding Roundup | Mergers & Acquisitions | Initial Public Offerings | Legal News
Neovasc advances warrant exchange from CardiAQ case
Neovasc (NSDQ:NVCN) said today that it inked an exchange deal for the last of the warrants it issued as part of a $65 million funding round to cover the damages from litigation with Edwards Lifesciences (NYSE:EW) subsidiary CardiAQ Valve. The Vancouver-based replacement heart valve developer said it plans to exchange the Series A and Series E warrants it […]
Bausch closes $1.5B debt offering, note redemption
Bausch Health (NYSE:BHC) said late last week that it closed a $1.5 billion offering of senior notes with funds raised slated to support the repurchasing of previously offered senior notes. The Quebec-based company said it closed an offering of $500 million in 5.75% senior secured notes due 2027 and that its Bausch Health Americas business, […]
Pops! Diabetes Care launches blood glucose monitoring system
Pops! Diabetes Care announced today the commercial launch of its blood glucose monitoring system. The Minneapolis-based company’s device won FDA clearance in December last year. Get the full story at our sister site, Drug Delivery Business News.
Fresenius preps $370m stock buyback
Fresenius (NYSE:FMS) said today that it’s planning a stock buyback of up to $370 million worth of its own shares. Shareholders in the German renal care giant said its shareholders approved the roughly 6-million-share buyback in May 2016. The €330 million repurchasing plan is slated to run from today through May 10, Fresenius said. If fully […]
Hill-Rom to acquire Voalte for $195m
Hill-Rom Holdings (NYSE:HRC) said yesterday that it inked a deal to acquire mobile healthcare communications developer Voalte in a deal worth up to $195 million. Through the deal, Chicago-based Hill-Rom will pay a cash consideration of $180 million and up to an additional $15 million in milestone-based payments. Hill-Rom said that the acquisition of Sarasota, Fla.-based […]
Smith & Nephew puts up $660m for Osiris Therapeutics
Smith & Nephew (NYSE:SNN) said today that it agreed to put $660 million on the table to acquire Osiris Therapeutics (NSDQ:OSIR) and its regenerative medicine portfolio. The British orthopedics and wound care giant said the $19-per-share deal is a 37% premium on the 90-day volume-weighted average for OSIR shares. It’s structured as a two-step tender […]
Ossio raises $22m for bio-integrative bone pins
Ossio said today that it closed a $22 million equity round led by OCV Partners. Existing investors Ortho Vision and Secocha Ventures also contributed to the orthopedic fixation company’s round. The Woburn, Mass.-based company said it plans to use its new funds to “accelerate strategic growth initiatives,” such as new product development, commercialization and talent […]
Cultivate(MD) buys into magnesium alloy developer
Genesis Innovation Group‘s Cultivate(MD) Capital Fund II said that it has invested in Magnesium Development Company (MDC), a firm with a breakthrough magnesium (Mg) alloy technology for orthopedic use. MDC designed its technology to combine the strength and handling properties of metal with complete, controllable absorption. Its magnesium alloy may be used in multiple applications to provide appropriate […]
Medtronic adds $6B to stock buyback plan
Medtronic (NYSE:MDT) said last week that its board of directors approved the addition of $6 billion to its existing stock buyback program. The existing $5 billion plan the board authorized in 2017 only has about $1.3 billion left, the Fridley, Minn.-based company said. Publicly trading companies often initiate share repurchasing programs to drive up their […]
RTI Surgical closes $300m Paradigm Spine buy
RTI Surgical (NSDQ:RTIX) said last week that it closed the $300 million acquisition of Paradigm Spine and its Coflex lumbar stenosis device. The cash-and-stock deal, originally announced last November, called for RTI to pay $100 million in cash and more than 10.7 million shares of its own stock worth $50 million, with the $150 million balance pegged to […]